InvestorsHub Logo
Followers 32
Posts 1683
Boards Moderated 0
Alias Born 01/11/2014

Re: None

Wednesday, 09/28/2016 2:58:46 PM

Wednesday, September 28, 2016 2:58:46 PM

Post# of 3831
Well, GALT failed, this is good for CNAT and GILD, the only two other players in Liver Cirrhosis. I am in CNAT too, Emricasan has shown efficacy in Humans. Anyway the good thing is that GALT was around $1.5 two months ago, so not much of a loss overall for who bought before summer, and i moved GALT money to CNAT to increase my position from today.
GLTA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News